A study to evaluate IPN10200 safety and efficacy in the prevention of episodic or chronic migraine in adults
A study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and anti-tumour activity of IPN01203 in adults with locally advanced or metastatic solid tumours exposed to immune checkpoint inhibitor therapies
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours